Purchase Order 75N91024P00364
Award Date 8/1/24
Potential Completion Date 7/31/25
Potential Value $134K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed-price purchase order was awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services (HHS), to Illumina, Inc. for $83,322.00. The contract provides for preventive maintenance, emergency service, support, and coverage for a government-owned Illumina NovaSeq 6000 sequencing system to support NCI's Comprehensive Oncologic Molecular Pathology and Sequencing Service (COMPASS) clinical...
- This firm fixed-price purchase order contract was awarded by the National Cancer Institute (NCI) to Illumina, Inc. for maintenance services on a government-owned Illumina NovaSeq 6000 DNA sequencer. The $735,959 contract has a base period of performance from March 2024 to March 2025 with four one-year option periods, and will provide preventative maintenance, remote technical support, emergency on-site repairs, and software updates to ensure uninterrupted research use of the specialized...
- This firm fixed-price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Illumina, Inc., a manufacturer of genetic sequencing systems and solutions, for preventive maintenance, emergency service, and support for a government-owned Illumina NovaSeq 6000 Sequencing System. The contract has a period of performance from August 1, 2022 to July 31, 2023 and a potential value of $119,523.28. The requirement was...
- The Department of Health and Human Services, National Institutes of Health, National Cancer Institute awarded a $130,847 firm fixed price purchase order to Illumina, Inc. of San Diego, California. The purpose is to procure preventive maintenance services for a government-owned Illumina NovaSeq 6000 Sequencing System located at the National Cancer Institute in Bethesda, Maryland. The Laboratory of Pathology requires these services to maintain optimal instrument operation, generate comparable...
- The National Cancer Institute (NCI) within the National Institutes of Health (NIH) awarded a $205,376.00 firm fixed price purchase order to Illumina, Inc. for maintenance services for a government-owned Illumina NextSeq 2000 sequencing system. The base period runs from February 1, 2024 through January 31, 2028, with the potential for three one-year extensions. The contract provides for annual preventative maintenance, remote technical support, and on-site emergency repairs within two business...
- This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Illumina, Inc. to maintain and provide preventive maintenance for a government-owned Illumina NextSeq 2000 desktop sequencer located at the NCI in Bethesda, Maryland. The contract has a ceiling value of $261,120.00 and a period of performance from June 12, 2023 to June 11, 2028. The contract does not have a set-aside designation. Illumina, a...
- This firm fixed price purchase order, awarded by the National Cancer Institute (NCI) at the National Institutes of Health (NIH), provides maintenance services for seven Illumina sequencing instruments and associated equipment. The $589,617.13 contract with Illumina, Inc., a manufacturer of genomic analysis solutions, has a performance period ending on August 31, 2026. The requirement was competed without any set-aside designation. The contract provides preventative maintenance and emergency...
- This is a firm-fixed-price purchase order awarded by the National Cancer Institute (NCI), which is part of the U.S. Department of Health and Human Services (DHHS), to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $336,139.00, is for preventive maintenance, emergency service, support, and coverage for a government-owned Illumina micro-array scanner with iScan and RoMa serviceable components. This equipment is critical for...
- This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH), National Cancer Institute (NCI) to Illumina, Inc. for preventive maintenance and repair services on an Illumina NextSeq 2000 sequencing instrument. The contract has a ceiling value of $234,449.00 and runs for an initial 12-month period with four 12-month option periods through August 2026. There is no set-aside designation. Illumina is the original equipment manufacturer (OEM) and the only...
- This is a firm fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH), to Illumina, Inc. for maintenance and repair services of Illumina's NovaSeq 6000 sequencing equipment. The contract has a ceiling value of $43,380.00 and a period of performance ending on October 12, 2025. The contract was awarded on a sole-source basis, as Illumina is the original equipment manufacturer of the NovaSeq 6000 sequencer....